Dr. Harris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
676 Teresita Blvd
San Francisco, CA 94127Phone+1 650-303-6205
Education & Training
- University of California San Francisco School of MedicinePost-Doctoral Fellowship, 1998 - 2001
- University of California (San Francisco) School of MedicineFellowship, Allergy and Immunology, 1997 - 1999
- University of California (San Francisco)Residency, Pediatrics, 1994 - 1997
- University of Florida College of MedicineClass of 1994
- University of FloridaPh.D., Neuroscience, Cum Laude, 1992
- University of FloridaB.S., Neuropharmacology, Magna Cum Laude, 1986
Certifications & Licensure
- CA State Medical License 1996 - 2022
Awards, Honors, & Recognition
- Predoctoral Research Fellowship in Neurobiology of Aging NIH
- President�s Award American Academy of Allergy, Asthma & Immunology (AAAAI)
- National Research Service Award NIH
- Join now to see all
Clinical Trials
- A Study of MEMP1972A in the Prevention of Allergen-Induced Airway Obstruction in Patients With Mild Asthma (SOLARIO) Start of enrollment: 2010 Dec 01
- A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- 50 citationsA randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria.Jeffrey M. Harris, Christopher R. Cabanski, Heleen Scheerens, Divya Samineni, Mary S. Bradley
The Journal of Allergy and Clinical Immunology. 2016-12-01 - 64 citationsA randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthmaJeffrey M. Harris, Romeo Maciuca, Mary S. Bradley, Christopher R. Cabanski, Heleen Scheerens
Respiratory Research. 2016-03-18 - 30 citationsMolecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzyme.Annie Arguello, Cathal S Mahon, Meredith E K Calvert, Darren Chan, Jason C Dugas
The Journal of Experimental Medicine. 2022-03-07
Journal Articles
- Increased IgE+ B cells in sputum, but not blood, bone marrow or tonsils, after inhaled allergen c challenge in asthmatic subjectsOliveria, JP, Salter, BS, MacLean, J, Kotwal, S, Smith, A, Harris, JM, Scheerens, H, Sehmi, R, GM Gauvreau, Am J Respir Crit Care Med, 1/1/2017
- Increased autophagy related 5 gene expression is associated with collagen expression in the airways of refractory asthmaticsPoon, AH, Choy, DF, Chouiali, F, Ramakrishnan, RK, Mahboub, B, Audusseau, S, Mogas, A, Harris, JM, Arron, JA, Laprise, C, Hamid Q, Frontiers in Immunology, 1/1/2017
- Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and LaunchScheerens, H, Malong, A, Bassett, K, Boyd, Z, Gupta, V, Harris, J, Mesick, C, Simnett, S, Stevens, H, Gilbert, H, Risser, P, Kalamegham, R, Jordan, J, Engel, J, Chen, ..., Clin Transl Sci, 1/1/2017
- Join now to see all
Lectures
- Results from QUAIL: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot Study of Quilizumab in Patients with Refractory Chronic Spontaneous Urticaria (CSU)Barcelona, Spain - 1/7/2015
Other
- Molecular Heterogeneity, Biomarker Discovery, and Targeted Therapy in Asthma in Yao, Jallal and RanadeArron, JR and Harris, JM, Genomic Biomarkers for Pharmaceutical Development: Advancing Personalized Health Care
1/1/2014 - Monoclonal Antibodies in Anti-inflammatory Therapy in Crommelin, Sindelar and MeibohmHarris, JM, Kuebler, P, Panzara MA, Pharmaceutical Biotechnology: Fundamentals & Applications 3rd Ed
1/1/2008 - Structural and immunological domain analysis of the carboxy-terminal tails of the high molecular weight neurofilament subunit proteins NF-M and NF-H (Dissertation)Harris JM, University of Florida � College of Medicine � Department of Neuroscience
1/1/1992
Press Mentions
- New Inhaled Drug Shows Promise Against Asthma, Allergies - US NewsJuly 2nd, 2014
Grant Support
- Thymic Impact On HIV-1 Immune ResponseNational Institute Of Allergy And Infectious Diseases2001–2003
- Thymic Impact On HIV-1 Immune ResponseNational Institute Of Allergy And Infectious Diseases2001
- Microglia As Mediators Of HIV Associated CNS DiseaseNational Institute Of Neurological Disorders And Stroke1998–2001
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: